Withdrawn
A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2023-04-14
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.
CONDITIONS
Official Title
The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
Not applicable - Study withdrawn since 04/23/1996
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here